Notice to attend the Annual General Meeting of Vitrolife AB (publ)
Vitrolife AB (VTRLY) has announced its Annual General Meeting scheduled for April 29, 2025 at Elite Park Avenue Hotel in Gothenburg, Sweden. Key proposals include a dividend of SEK 1.10 per share with a record date of May 2, 2025.
The Election Committee proposes maintaining a five-member board, with Jón Sigurdsson continuing as Chairman. Total board remuneration is proposed to increase by 11.2% to SEK 3,670,000, with the Chairman's compensation set at SEK 1,350,000.
Shareholders must be recorded in Euroclear Sweden AB's register by April 17, 2025, and notify their attendance by April 23, 2025. The meeting will also address the re-election of Deloitte AB as auditor and authorizations for new share issuance and company share buybacks.
Vitrolife AB (VTRLY) ha annunciato la sua Assemblea Generale Annuale programmata per il 29 aprile 2025 presso l'Elite Park Avenue Hotel di Gothenburg, Svezia. Le proposte principali includono un dividendo di SEK 1,10 per azione con una data di registrazione fissata al 2 maggio 2025.
Il Comitato Eletto propone di mantenere un consiglio di amministrazione composto da cinque membri, con Jón Sigurdsson che continuerà come Presidente. Si propone un aumento del 11,2% della remunerazione totale del consiglio a SEK 3.670.000, con la compensazione del Presidente fissata a SEK 1.350.000.
Gli azionisti devono essere registrati nel registro di Euroclear Sweden AB entro il 17 aprile 2025 e notificare la loro presenza entro il 23 aprile 2025. L'incontro affronterà anche la rielezione di Deloitte AB come revisore e le autorizzazioni per l'emissione di nuove azioni e per il riacquisto di azioni della società.
Vitrolife AB (VTRLY) ha anunciado su Junta General Anual programada para el 29 de abril de 2025 en el Elite Park Avenue Hotel en Gotemburgo, Suecia. Las propuestas clave incluyen un dividendo de SEK 1,10 por acción con una fecha de registro del 2 de mayo de 2025.
El Comité de Elección propone mantener una junta de cinco miembros, con Jón Sigurdsson continuando como Presidente. Se propone un aumento del 11,2% en la remuneración total de la junta a SEK 3.670.000, con la compensación del Presidente fijada en SEK 1.350.000.
Los accionistas deben estar registrados en el registro de Euroclear Sweden AB antes del 17 de abril de 2025 y notificar su asistencia antes del 23 de abril de 2025. La reunión también abordará la reelección de Deloitte AB como auditor y las autorizaciones para la emisión de nuevas acciones y la recompra de acciones de la empresa.
Vitrolife AB (VTRLY)는 2025년 4월 29일 스웨덴 예테보리의 Elite Park Avenue Hotel에서 예정된 연례 총회를 발표했습니다. 주요 제안 사항에는 주당 1.10 SEK의 배당금과 2025년 5월 2일의 기록일이 포함됩니다.
선거위원회는 5명의 이사로 구성된 이사회를 유지할 것을 제안하며, Jón Sigurdsson은 의장으로 계속 활동합니다. 이사회의 총 보수는 SEK 3,670,000으로 11.2% 증가할 것이며, 의장의 보수는 SEK 1,350,000으로 설정됩니다.
주주들은 2025년 4월 17일까지 Euroclear Sweden AB의 등록부에 기록되어야 하며, 2025년 4월 23일까지 참석 여부를 통지해야 합니다. 이 회의에서는 Deloitte AB의 감사 재선임과 새로운 주식 발행 및 회사 주식 매입에 대한 권한도 다룰 것입니다.
Vitrolife AB (VTRLY) a annoncé sa réunion générale annuelle prévue pour le 29 avril 2025 à l'Elite Park Avenue Hotel à Göteborg, Suède. Les propositions clés incluent un dividende de SEK 1,10 par action avec une date de référence fixée au 2 mai 2025.
Le comité de nomination propose de maintenir un conseil d'administration de cinq membres, avec Jón Sigurdsson continuant en tant que président. La rémunération totale du conseil est proposée d'augmenter de 11,2 % pour atteindre SEK 3.670.000, la compensation du président étant fixée à SEK 1.350.000.
Les actionnaires doivent être enregistrés dans le registre d'Euroclear Sweden AB d'ici le 17 avril 2025 et notifier leur présence d'ici le 23 avril 2025. La réunion abordera également la réélection de Deloitte AB en tant qu'auditeur et les autorisations pour l'émission de nouvelles actions et les rachats d'actions de l'entreprise.
Vitrolife AB (VTRLY) hat seine Jahreshauptversammlung für den 29. April 2025 im Elite Park Avenue Hotel in Göteborg, Schweden, angekündigt. Zu den wichtigsten Vorschlägen gehört eine Dividende von SEK 1,10 pro Aktie mit einem Stichtag am 2. Mai 2025.
Der Wahlvorstand schlägt vor, einen fünfköpfigen Vorstand beizubehalten, wobei Jón Sigurdsson weiterhin Vorsitzender bleibt. Die Gesamtvergütung des Vorstands wird um 11,2% auf SEK 3.670.000 erhöht, wobei die Vergütung des Vorsitzenden auf SEK 1.350.000 festgelegt wird.
Die Aktionäre müssen bis zum 17. April 2025 im Register von Euroclear Sweden AB eingetragen sein und ihre Teilnahme bis zum 23. April 2025 melden. In der Sitzung wird auch die Wiederwahl von Deloitte AB als Prüfer sowie die Genehmigungen für die Ausgabe neuer Aktien und Aktienrückkäufe behandelt.
- None.
- None.
Shareholders who wish to attend the Annual General Meeting must:
- be recorded in the share register prepared by Euroclear Sweden AB relating to the circumstances on 17 April 2025; and
- notify their attendance in accordance with the instructions in the Notice by 23 April 2025.
Shareholders who have had their shares registered with a nominee through a bank or other nominee must temporarily register the shares in their own name in the share register kept by Euroclear Sweden AB in order to participate in the meeting. Shareholders who wish to participate in the AGM by postal voting must give notice of their participation by casting their postal votes in accordance with the instructions under the heading Postal voting in the notice so that the postal votes are received by Euroclear Sweden AB no later than 23 April 2025.
The following proposals will be amongst those presented at the Annual General Meeting:
- The Board of Directors proposes a dividend of
SEK 1.10 per share and 2 May 2025 as the record day for the dividend. - The Election Committee proposes that the Board shall consist of five members. The Election Committee proposes re-election of the Board members Lars Holmqvist, Pia Marions, Henrik Blomquist, Karen Lykke Sørensen and Jón Sigurdsson. It is proposed that Jón Sigurdsson is the Chairman of the Board.
- Remuneration to the Board members is proposed to be in total SEK 3 670 000 (3 300 000) of which
SEK 1 350 000 (1 200 000) to the Chairman of the Board,SEK 450 000 (400 000) to each of the other members of the Board,SEK 160 000 (150 000) to the Chairman of the Audit Committee andSEK 80 000 (75 000) to each of the other members of the Audit Committee. No changes in the remuneration of the members of the Remuneration Committee. The proposal means an increase corresponding to11.2% in total. - The Election Committee proposes to re-elect Deloitte AB as auditor with unchanged remuneration principles.
- Authorization for the Board to resolve to issue new shares up until the next Annual General Meeting.
- Authorization for the Board to resolve on acquisition of the company's own shares up until the next Annual General Meeting.
Attachment: Full notice
VITROLIFE AB (publ)
The Board of Directors
The information was submitted for publication, through the agency of the contact persons set out above, at 25-03-2025 18:30 CET.
CONTACT:
Contact:
Jón Sigurdsson, Chairman of the Board, email: jon@emblamedical.com
Helena Wennerström, Acting CFO, email: hwennerstrom@vitrolife.com
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Notice to attend the Annual General Meeting of Vitrolife AB (publ) |
View original content:https://www.prnewswire.com/news-releases/notice-to-attend-the-annual-general-meeting-of-vitrolife-ab-publ-302411084.html
SOURCE Vitrolife AB (publ)
FAQ
What is the proposed dividend for Vitrolife (VTRLY) shareholders in 2025?
When and where is Vitrolife's 2025 Annual General Meeting?
What are the key board remuneration changes proposed for VTRLY in 2025?
What is the deadline for Vitrolife shareholders to register for the 2025 AGM?
Who is proposed to serve on Vitrolife's Board of Directors for 2025?
